{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Welcome to the Arena from ICR – Conversations with Today's Innovators & Business Leaders","title":"Thomas Sandgaard, Founder, Chairman, President, and CEO, Zynex Medical – Electrifying the Industry: Revolutionizing chronic pain care with innovative service and solutions","html":"","width":"100%","height":180,"duration":1804,"description":"There's a reason it's called healthcare – care and carefulness are at the core, and if you want to be successful in the field, you've got to understand the significance of compliance, exceptional service, and continuous expansion. Today's guest has mastered that formula. \nWe're sitting down with Thomas Sandgaard who is Chairman, President, and CEO of Zynex, which trades on the NASDAQ under the symbol ZYXI. Thomas founded the company in 1996, but before that, he held management positions with companies such as ITT, Siemens, GN Danavox DataCo, and Phillips. \nThomas is also the Founder and CEO of Sandgaard Capital, a private equity investment firm and family office. Additionally, he's the Founder and President of the Sandgaard Foundation, which seeks to address the tragic opioid and fentanyl crisis here in the States by helping to fund initiatives that save lives from overdoses, help people escape the cycle of relapse, and support victims and their families. \n\nThomas has a degree in electronic engineering from Denmark's Syddansk University, Engineering, and an MBA from Copenhagen Business School. \nHighlights:\nZynex's background and business model (3:57)\nHow Thomas got into the medical device industry (5:39)\nThe pain management market (7:04)\nZynex's target audiences (8:17)\nCompetition in the field (9:14)\nZynex's line of products (10:37) \nThomas explains Zynex's total addressable market (11:21)\nPatient monitoring part of the business (12:56)\nHow Zynex builds and maintains their sales force (14:45)\nThomas' philosophy on customer service (17:22)\nHow Zynex is diversifying its product range (18:10)\nThomas describes how he prioritizes investments and balances growth and profitability (19:16)\nZynex's first quarter growth reports (20:38)\nZynex's new M-Wave NMES device (21:48)\nThomas' take on the barriers to entry in the medical device industry (23:13)\nThomas' work as a musician (24:38)\nThe Sandgaard Capital Foundation and its mission (25:55)\nLinks:\nThomas Sandgaard on...","thumbnail_url":"https://img.transistorcdn.com/VPbFZOgoHk78hrWlplrfMSrQROUNxI8jcZ2Gv-hyKm4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mYmFh/NWFlNGJjY2Y0NGFk/YmM2NWJiMTI4NmVh/OWQ4Yi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}